Breast Cancer
Conference Coverage
First-in-class ADC ups survival in mTNBC
Sacituzumab govitecan prolonged progression-free and overall survival.
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
News
AI algorithm on par with radiologists as mammogram reader
Combining the algorithm with first-reader radiologists revealed more breast cancer cases than combining first- and second-reader radiologists.
News
Study supports multigene panel testing for all breast cancer patients with second primary cancers
The results could lead to better implementation of cancer prevention and screening strategies, according to researchers.
News
Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 results
Negative results from the IMpassion131 trial may jeopardize the U.S. approval of atezolizumab in breast cancer.
News
Hair dye and cancer study ‘offers some reassurance’
Opinion
Chronicles of Cancer: A history of mammography, part 2
The history of mammography is rife with controversy, enmeshed in the War on Cancer, corporate and professional interests, and the women’s rights...
Article
A Rare Case of Triple Positive Inflammatory Breast Cancer in An Elderly Male
Conference Coverage
VTE, sepsis risk increased among COVID-19 patients with cancer
Cancer patients had significantly lower hemoglobin levels, platelet counts, and red and white blood cell counts.
News
First guideline on NGS testing in cancer, from ESMO